GABRIELLE HAYDEN: Open Payments
NPI 1982156402 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,524 in 65 payments from 19 companies in 2025. Trend: 2023 $5,923 · 2024 $10,347 · 2025 $1,524
Food & beverage: $1,524
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $329 |
| ABBVIE INC. | 17 | $326 |
| Janssen Biotech, Inc. | 18 | $285 |
| UCB, Inc. | 3 | $88 |
| Amgen Inc. | 3 | $67 |
| Galderma Laboratories, L.P. | 2 | $58 |
| Lilly USA, LLC | 2 | $50 |
| PFIZER INC. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $39 |
Products named: DUPIXENT, TREMFYA, BOTOX, SKYRIZI, Bimzelx, RINVOQ, Otezla, NEMLUVIO.
Industry payments across OH — which companies pay providers there.
